发明名称 COMBINATION TREATMENT FOR ROSACEA
摘要 The invention relates to a method of treating erythema and/or telangiectasia associated with rosacea in a patient in need thereof by topically administering an effective amount of a combination of brimonidine or a pharmaceutically acceptable salt thereof and oxymetazoline or a pharmaceutically acceptable salt thereof to the site of erythema and/or telangiectasia on the skin of the patient. The invention further relates to topical compositions including the combination of compounds and a pharmaceutically acceptable carrier.
申请公布号 US2015313894(A1) 申请公布日期 2015.11.05
申请号 US201514797519 申请日期 2015.07.13
申请人 Galderma Laboratories Inc. 发明人 Graeber Michael;Leoni Matthew James;Wagner Nathalie
分类号 A61K31/498;A61K9/00;A61K31/4174 主分类号 A61K31/498
代理机构 代理人
主权项 1. A method for treating erythema associated with rosacea in a patient in need thereof, the method comprising topically administering an effective amount of a combination of brimonidine or a pharmaceutically acceptable salt thereof and oxymetazoline or a pharmaceutically acceptable salt thereof to the site of erythema on the skin of the patient.
地址 Fort Worth TX US